Sign in
ANIP Stock Price, Chart, Stats & News
ANI Pharmaceuticals, Inc.
Save
ANI Pharmaceuticals, Inc. (ANIP) does not currently pay a dividend.
1.87B
Market cap
9.98x
Current P/E
10.42x
Forward P/E
ANIP chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 69.08% |
Operating margin | 12.58% |
Pretax margin | 10.84% |
Net margin | 8.59% |
Effective tax rate | 18.22% |
ROA | 5.27% |
ROE | 15.55% |
D/E | 0.60x |
Interest coverage ratio | 2.53x |
ANIP valuation
P/E | 9.98x |
P/S | 1.85x |
P/B | 2.70x |
P/CF | 7.88x |
P/FCF | 12.73x |
P/OCF | 7.88x |
PEG | 0.18x |
EV multiple | 7.07x |
About
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products.
Similar securities
Based on sector and market capitalization
Report issue